Advertisement
U.S. markets closed

AngioDynamics, Inc. (ANGO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
5.79-0.20 (-3.34%)
At close: 04:00PM EST
5.79 0.00 (0.00%)
After hours: 04:37PM EST

AngioDynamics, Inc.

14 Plaza Drive
Latham, NY 12110
United States
518 795 1400
https://www.angiodynamics.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees815

Key Executives

NameTitlePayExercisedYear Born
Mr. James C. ClemmerCEO, President & Director982.92kN/A1964
Mr. Stephen A. TrowbridgeExecutive VP & CFO528.02k79.25k1974
Mr. Chad T. CampbellSenior VP and GM of Vascular Access & Oncology Global Business Unit416.51kN/A1971
Ms. Laura PiccininiSenior VP & GM of International444.31kN/A1969
Mr. Saleem M. CheeksVice President of CommunicationsN/AN/AN/A
Mr. Benjamin H. DavisSenior Vice President of Business DevelopmentN/AN/A1964
Ms. Marna I. Bronfen-MooreSenior Vice President of Human ResourcesN/AN/A1967
Mr. Warren G. NighanSenior Vice President of Quality & Regulatory Affairs622.11kN/A1969
Ms. Kim L. SeaburySenior Vice President of Information TechnologyN/AN/A1967
Mr. Scott CenteaSenior VP & GM of Endovascular Therapies558.54kN/A1979
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Corporate Governance

AngioDynamics, Inc.’s ISS Governance QualityScore as of February 1, 2024 is 5. The pillar scores are Audit: 9; Board: 3; Shareholder Rights: 6; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.